Clinical Trials Browser

Phase NA × Interventional × G250 monoclonal antibody × Clear all

NCT00602862 2013-12-02

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Phase NA Completed

Carcinoma, Renal Cell